CEO
Inflammatix, Inc
Dr. Sweeney is co-founder and CEO of Inflammatix, Inc., which is focused on bringing to market novel multi-RNA diagnostic signatures for acute infections and sepsis. Dr. Sweeney completed his MD/PhD at Duke University, and then spent time training in the general surgery residency program at Stanford University. During his residency research years, he completed a postdoc MS in Biomedical Informatics at Stanford, during which he worked with Dr. Purvesh Khatri to identify a new way to diagnose infections based on ‘reading’ the immune system. Their work designing custom informatics algorithms for sifting through heterogeneous large datasets led to the core technology on which Inflammatix is based.